Hpv

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.

HPV is the most common sexually transmitted infection, yet many people lack knowledge of the infection or hold several misconceptions about it.

Researchers found that maternal morbidity risks were higher among women who underwent in vitro fertilization or intrauterine insemination vs. those who had unassisted pregnancies.

Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received testing had HPV persistence or progression.

HPV-based screening was superior to cytology in preventing invasive cervical cancer in real-world settings in Sweden, according to a randomized trial published in Lancet Public Health.

Throughout 2024, data surrounding STDs came in waves of good and bad news, with data showing slower rates of infection and even disease elimination intermingling with news of hospitals failing to follow CDC guidance.

Cervical cancer mortality among U.S. women younger than 25 years declined by 62% between 2013 and 2021, a finding largely attributed to the wide availability of HPV vaccination for this age cohort, researchers reported in JAMA.

Anal high-risk HPV and abnormal cytology were common among transgender women regardless of their age, HIV status and/or hormone use, researchers determined.

HPV vaccination programs for adults aged 27 to 45 years could benefit certain subgroups but are ultimately more costly and less effective vs. vaccination of those aged younger than 26 years, data show.

Many midlife women experience hypoactive sexual desire disorder, which can impact both relationships and mental health, but two FDA approved treatments are available, according to a speaker at the Annual Meeting of The Menopause Society.